These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12942863)
1. [Economic impact of generic substitution in the southwest of France: study of prescription and delivery of generic drugs based on Caisse Primaire d'Assurance Maladie de la Haute-Garonne data ]. Roussel-Navarro V; Bagheri H; Montastruc JL; Taillefer G; Bez J; Lapeyre-Mestre M Therapie; 2003; 58(2):175-7. PubMed ID: 12942863 [No Abstract] [Full Text] [Related]
2. [Generic drugs and the rights of substitution]. Vallée JP Presse Med; 1999 Mar; 28(10):535-8. PubMed ID: 10209545 [TBL] [Abstract][Full Text] [Related]
4. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality. Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274 [No Abstract] [Full Text] [Related]
5. Generic drugs: an overview. Helgeland D S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165 [No Abstract] [Full Text] [Related]
6. The impact of generic substitution on price competition in Finland. Aalto-Setälä V Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226 [TBL] [Abstract][Full Text] [Related]
7. Generic drug prescriptions following hospital discharge: a prospective study in France. Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042 [TBL] [Abstract][Full Text] [Related]
8. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective. Emanuele E South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163 [No Abstract] [Full Text] [Related]
10. [Generic prescription by the physician is better than generic substitution by the pharmacy]. Jakobsson S; Dahlqvist R; Håkansson J; Widäng K Lakartidningen; 2002 Mar; 99(10):1098-9. PubMed ID: 12024789 [No Abstract] [Full Text] [Related]
11. Impact of generic and therapeutic interchange incentives on community pharmacy. Carroll NV Am Pharm; 1995 Jul; NS35(7):27-34. PubMed ID: 7661103 [TBL] [Abstract][Full Text] [Related]
12. Potential savings from generic prescribing and generic substitution in South Africa. Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460 [TBL] [Abstract][Full Text] [Related]
13. When is a "generic" medication not really a generic? Howland RH J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651 [TBL] [Abstract][Full Text] [Related]
14. Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs. Ann Intern Med; 2005 Jun; 142(11):I30. PubMed ID: 15941691 [No Abstract] [Full Text] [Related]
16. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001. Tilson L; McGowan B; Ryan M; Barry M Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759 [TBL] [Abstract][Full Text] [Related]
17. A physician survey on generic drugs and substitution of critical dose medications. Banahan BF; Kolassa EM Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664 [TBL] [Abstract][Full Text] [Related]
19. [Generic drugs and right of substitution. Relating to Article 29 of the 1999 *social Security Financing Act]. Meunier J; Thuillier A Ann Pharm Fr; 1999 Jul; 57(4):340-8; discussion 348-9. PubMed ID: 10472707 [TBL] [Abstract][Full Text] [Related]
20. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement. Murry L; Gerleman B; Urick B; Urmie J J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]